The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Related Articles
Frontiers | Natural killer cell engagers for cancer immunotherapy
1 Department of Pharmaceutics, Rutgers University, Piscataway, NJ, United States 2 Cancer Pharmacology Program, Cancer Institute of New Jersey, New Brunswick, NJ, United States This…
Judge temporarily blocks Trump administration from placing 2,200 USAID workers on paid leave
A federal judge has temporarily blocked the Trump administration from placing 2,200 employees of the U.S. Agency for International Development on paid leave. U.S.
Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy
This cohort study examines the response and survival rates associated with ipilimumab-nivolumab therapy in patients with progressive melanoma brain metastases after anti–programmed cell death 1…
LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Abstract. Repeat element viral mimicry is a common feature in pancreatic ductal adenocarcinoma (PDAC) that require mechanisms to manage this repeat “viral” load and attenuate…
Hidden in Plain Sight: Clinical Imaging of the Tumor Microenvironment with PET
Summary:. PET imaging enables the spatiotemporal assessment of tumor biomarkers. In this issue, Kong and colleagues describe the clinical PET imaging of tumor-associated fibroblasts, which…
3D tumor maps give researchers an unprecedented look at cancer growth
By detailing every single cell in aggressive cancers, researchers hope to fuel therapeutic discoveries
Common Sense Nutriton: A Pragmatic Approach to an Issue Made Complicated
Nutrition, like many areas where academia has meddled too strongly, has become a rather complicated topic these days. We used to eat food for nutrition.…
Stromal KITL/SCF maintains pancreas tissue homeostasis and restrains tumor progression
Abstract. Components of normal tissue architecture serve as barriers to tumor progression. Inflammatory and wound-healing programs are requisite features of solid tumorigenesis, wherein alterations to…
1-year efficacy results after MR-guided risk-adapted stereotactic radiotherapy of infra-diaphragmatic oligometastases in a multicenter phase II trial
During the last decade, several research groups have succeeded in recruiting to randomized controlled trials and reported the outcome of the use of stereotactic ablative…
